Abliance SAS

21, Quai du Clos des Roses, 60200 Compiegne

Telephone +33 3 44206130
Fax +33 3 44206255

This company is co-exhibitor of
Business France


Hall map

MEDICA 2016 hall map (Hall 3): stand H74

Fairground map

MEDICA 2016 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.07  Haemostasisreagents (Coagulation)

Our products

Product category: Haemostasisreagents (Coagulation)


Reagent for determination of Prothrombin time (PT) in human plasma
The method uses Quick and al. method.
Tissue thromboplastin and calcium are added to citrated plasma, activating the factors of extrinsic coagulation pathway. The clotting time (time to formation of a fibrin clot) is measured at 37°C.

More Less

Product category: Haemostasisreagents (Coagulation)


Reagent for determination of activated partial thromboplastin time (APTT) in human plasma
In presence of standardized amount of phospholipids (Cephalin), calcium chloride, and activator (kaolin), the factors of intrinsic coagulation system in citrated plasma are activated. The clotting time is measured.

 Clinical interest
The measure of APTT is a common coagulation test used for investigation of intrinsic coagulation pathway (factors VIII, IX, XI, XII, V, X, II and I). It is commonly used to monitor heparin therapy.
Abnormal APTT may require further investigations related to congenital or acquired deficiencies and should not be made a single test.

More Less

Product category: Haemostasisreagents (Coagulation)


Calibration plasma for fibrinogen and PT INR (determination of reference time)

More Less

Product category: Haemostasisreagents (Coagulation)


Coagulation Control Level I and Level II
For intralaboratory Quality Control
For use as normal and abnormal controls during coagulation tests


More Less

Product category: Haemostasisreagents (Coagulation)


Reagent for quantitative determination of Fibrinogen in human plasma
The method uses Von Clauss and al. method.

In the presence of an excess of thrombin, the time of formation of the fibrin clot in the plasma (pre-diluted) is reversely proportional to the amount of fibrinogen in the sample. The clotting time is measured at 37°C.

Clinical interest
Fibrinogen is a glycoprotein (340 KDa) synthesised by liver and present in the plasma at a level within 2 to 4 g/L.
The concentration of fibrinogen is increased in infections, estrogens ingestion, tissue necrosis, obesity, pregnancies and diabetes. An increase of fibrinogen is also involved as a risk factor for coronary artery disorders and cerebrovascular diseases.
A decrease of fibrinogen in plasma is associated with:
- liver diseases (cirrhosis, jaundice)
- Fibrinolysis or disseminated intravascular coagulation (DIC)

More Less

About us

Company details

ABLIANCE is a french antibody manufacturer.

ABLIANCE provides monoclonal antibody development and production services as well as a wide range of secondary antibodies.

ABLIANCE’s clients are Major healthcare companies and Startups who have heavy regulatory and standardizing requirements. Our scientific expertise and our high level of traceability perfectly match with the future challenges of our clients.

More Less

Company data

Sales volume

< 1 Mio US $

Export content

max. 50%

Number of employees




Area of business